Affiliations
AffiliationItem in Clipboard
Clinical and pathologic features of familial pancreatic cancerJeremy L Humphris et al. Cancer. 2014.
Free article . 2014 Dec 1;120(23):3669-75. doi: 10.1002/cncr.28863. Epub 2014 Oct 14. Authors Jeremy L Humphris 1 , Amber L Johns, Skye H Simpson, Mark J Cowley, Marina Pajic, David K Chang, Adnan M Nagrial, Venessa T Chin, Lorraine A Chantrill, Mark Pinese, R Scott Mead, Anthony J Gill, Jaswinder S Samra, James G Kench, Elizabeth A Musgrove, Katherine M Tucker, Allan D Spigelman, Nic Waddell, Sean M Grimmond, Andrew V Biankin; Australian Pancreatic Cancer Genome Initiative AffiliationItem in Clipboard
AbstractBackground: Inherited predisposition to pancreatic cancer contributes significantly to its incidence and presents an opportunity for the development of early detection strategies. The genetic basis of predisposition remains unexplained in a high proportion of patients with familial PC (FPC).
Methods: Clinicopathologic features were assessed in a cohort of 766 patients who had been diagnosed with pancreatic ductal adenocarcinoma (PC). Patients were classified with FPC if they had ≥1 affected first-degree relatives; otherwise, they were classified with sporadic PC (SPC).
Results: The prevalence of FPC in this cohort was 8.9%. In FPC families with an affected parent-child pair, 71% in the subsequent generation were 12.3 years younger at diagnosis. Patients with FPC had more first-degree relatives who had an extrapancreatic malignancy (EPM) (42.6% vs 21.2; P<.0001), particularly melanoma and endometrial cancer, but not a personal history of EPM. Patients with SPC were more likely to be active smokers, have higher cumulative tobacco exposure, and have fewer multifocal precursor lesions, but these were not associated with differences in survival. Long-standing diabetes mellitus (>2 years) was associated with poor survival in both groups.
Conclusions: FPC represents 9% of PC, and the risk of malignancy in kindred does not appear to be confined to the pancreas. Patients with FPC have more precursor lesions and include fewer active smokers, but other clinicopathologic factors and outcome are similar to those in patients with SPC. Furthermore, some FPC kindreds may exhibit anticipation. A better understanding of the clinical features of PC will facilitate efforts to uncover novel susceptibility genes and the development of early detection strategies.
Keywords: epidemiology; hereditary; pancreatic cancer; prognosis.
© 2014 American Cancer Society.
Similar articlesYeo TP, Hruban RH, Brody J, Brune K, Fitzgerald S, Yeo CJ. Yeo TP, et al. J Gastrointest Surg. 2009 Aug;13(8):1487-94. doi: 10.1007/s11605-009-0923-6. Epub 2009 May 21. J Gastrointest Surg. 2009. PMID: 19459017
Catts ZA, Baig MK, Milewski B, Keywan C, Guarino M, Petrelli N. Catts ZA, et al. Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4. Ann Surg Oncol. 2016. PMID: 26727920
Takai E, Yachida S, Shimizu K, Furuse J, Kubo E, Ohmoto A, Suzuki M, Hruban RH, Okusaka T, Morizane C, Furukawa T. Takai E, et al. Oncotarget. 2016 Nov 8;7(45):74227-74235. doi: 10.18632/oncotarget.12490. Oncotarget. 2016. PMID: 27732944 Free PMC article.
Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Matsubayashi H, et al. World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. World J Gastroenterol. 2017. PMID: 28246467 Free PMC article. Review.
Ohmoto A, Yachida S, Morizane C. Ohmoto A, et al. Int J Mol Sci. 2019 Jan 29;20(3):561. doi: 10.3390/ijms20030561. Int J Mol Sci. 2019. PMID: 30699894 Free PMC article. Review.
Petersen GM. Petersen GM. Hematol Oncol Clin North Am. 2015 Aug;29(4):641-53. doi: 10.1016/j.hoc.2015.04.007. Epub 2015 Jun 9. Hematol Oncol Clin North Am. 2015. PMID: 26226902 Free PMC article. Review.
Eissa MAL, Lerner L, Abdelfatah E, Shankar N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F, Wolfgang C, Kwak R, Ruiz M, Tam M, Pisanic TR 2nd, Iacobuzio-Donahue CA, Hruban RH, He J, Wang TH, Wood LD, Sharma A, Ahuja N. Eissa MAL, et al. Clin Epigenetics. 2019 Apr 5;11(1):59. doi: 10.1186/s13148-019-0650-0. Clin Epigenetics. 2019. PMID: 30953539 Free PMC article.
Paranal RM, Wood LD, Klein AP, Roberts NJ. Paranal RM, et al. Fam Cancer. 2024 Nov;23(4):419-428. doi: 10.1007/s10689-024-00383-2. Epub 2024 Apr 12. Fam Cancer. 2024. PMID: 38609521 Review.
Liu P, Ying Q, Liu H, Yu SQ, Bu LP, Shao L, Li XY. Liu P, et al. Oncol Rep. 2020 Oct;44(4):1393-1402. doi: 10.3892/or.2020.7713. Epub 2020 Aug 3. Oncol Rep. 2020. PMID: 32945513 Free PMC article.
Pelosi E, Castelli G, Testa U. Pelosi E, et al. Biomedicines. 2017 Nov 18;5(4):65. doi: 10.3390/biomedicines5040065. Biomedicines. 2017. PMID: 29156578 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3